ID: h-debate-05624b1daee6
Hypothesis

Autophagosome Marker Hijacking Strategy

Design therapeutics that mimic or enhance LC3-tau interactions to redirect tau-containing vesicles into autophagic clearance pathways.
🧬 MAP1LC3A🎯 Composite 0%💱 $0.51▲1.1%proposed
molecular biology
EvidenceModerate (50%)📖 0 cit🗣 1 debates 1 support 0 oppose
✓ All Quality Gates Passed
Mechanistic 0.60 (15%) Evidence 0.55 (15%) Novelty 0.60 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.000 composite

🧪 Overview

Design therapeutics that mimic or enhance LC3-tau interactions to redirect tau-containing vesicles into autophagic clearance pathways. This leverages existing cellular machinery while maintaining selectivity for pathological tau.

Debate provenance: derived from debate `sess_SDA-2026-04-08-gap-debate-20260406-062052-81a54bfd` on question: The debate identified fundamental druggability challenges for these targets due to their essential roles, but specific molecular approaches to achieve selectivity for tau-containing vesicles versus normal cellular functions were not resolved. Novel targeting strategies are needed.

Source: Debate se. Consensus signal: skeptic, synthesizer, theorist discussed the mechanism terms Autophagosome, Hijacking, LC3, MAP1LC3A, Marker, Strategy, clearance. Novelty signal: skeptic-discussed-with-qualified-concession.

🧬 Mechanism

🔗 Mechanism from KG for MAP1LC3A

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    MAPT["MAPT"] -->|modulates| autophagy_pathway["autophagy pathway"]
    MAP1LC3A["MAP1LC3A"] -->|regulates| autophagy_pathway_1["autophagy pathway"]
    MAPT_2["MAPT"] -->|interacts with| MAP1LC3A_3["MAP1LC3A"]
    HSPA1A["HSPA1A"] -->|regulates| protein_folding["protein folding"]
    HSP70_modulators["HSP70 modulators"] -.->|inhibits| MAPT_aggregation["MAPT aggregation"]
    HSP90_inhibitors["HSP90 inhibitors"] -->|modulates| MAPT_4["MAPT"]
    chaperones["chaperones"] -->|selectively target| misfolded_proteins["misfolded proteins"]
    autophagy_pathway_5["autophagy pathway"] -->|clearance mechanis| pathological_tau["pathological tau"]
    HSPA1A_6["HSPA1A"] -->|selectively target| mis_folded_MAPT["mis folded MAPT"]
    MAPT_7["MAPT"] -->|causes| membrane_lipid_asymmetry["membrane lipid asymmetry"]
    MAPT_8["MAPT"] -->|disrupts| vesicular_pH_homeostasis["vesicular pH homeostasis"]
    MAPT_9["MAPT"] -->|causes| phosphatidylserine_exposu["phosphatidylserine exposure"]
    style MAPT fill:#4fc3f7,stroke:#333,color:#000
    style autophagy_pathway fill:#81c784,stroke:#333,color:#000
    style MAP1LC3A fill:#4fc3f7,stroke:#333,color:#000
    style autophagy_pathway_1 fill:#81c784,stroke:#333,color:#000
    style MAPT_2 fill:#4fc3f7,stroke:#333,color:#000
    style MAP1LC3A_3 fill:#4fc3f7,stroke:#333,color:#000
    style HSPA1A fill:#4fc3f7,stroke:#333,color:#000
    style protein_folding fill:#81c784,stroke:#333,color:#000
    style HSP70_modulators fill:#4fc3f7,stroke:#333,color:#000
    style MAPT_aggregation fill:#4fc3f7,stroke:#333,color:#000
    style HSP90_inhibitors fill:#4fc3f7,stroke:#333,color:#000
    style MAPT_4 fill:#4fc3f7,stroke:#333,color:#000
    style chaperones fill:#4fc3f7,stroke:#333,color:#000
    style misfolded_proteins fill:#4fc3f7,stroke:#333,color:#000
    style autophagy_pathway_5 fill:#81c784,stroke:#333,color:#000
    style pathological_tau fill:#4fc3f7,stroke:#333,color:#000
    style HSPA1A_6 fill:#4fc3f7,stroke:#333,color:#000
    style mis_folded_MAPT fill:#4fc3f7,stroke:#333,color:#000
    style MAPT_7 fill:#4fc3f7,stroke:#333,color:#000
    style membrane_lipid_asymmetry fill:#4fc3f7,stroke:#333,color:#000
    style MAPT_8 fill:#4fc3f7,stroke:#333,color:#000
    style vesicular_pH_homeostasis fill:#4fc3f7,stroke:#333,color:#000
    style MAPT_9 fill:#4fc3f7,stroke:#333,color:#000
    style phosphatidylserine_exposu fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — MAP1LC3A

No curated PDB or AlphaFold mapping for MAP1LC3A yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for MAP1LC3A →

No DepMap CRISPR Chronos data found for MAP1LC3A.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0002
Events (7d)
1
Price History
▲1.1%

💾 Resource Usage

LLM Tokens
9,536
$0.0572
Total Cost
$0.0572
Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
sourcev1_phase_c_backfill
origin_typedebate_round_mining
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.